Theory and Practice artwork

Theory and Practice

77 episodes - English - Latest episode: 6 months ago - ★★★★★ - 43 ratings

Season 4 will explore one of humanity's most rapidly advancing and impactful changes: what does it mean to be human in the age of AI when computers and robots are accomplishing more human functions? How will AI with human-level skills influence us and enhance the world around us? How will we change AI, and how will it change us?


Theory and Practice opens the doors to the cutting edge of biology and computer science through conversations with leaders in the field. The podcast is hosted by Anthony Philippakis (a cardiologist, genomicist, and Venture Partner at GV) and Alex Wiltschko (neuroscientist, AI researcher, CEO of Osmo, and Entrepreneur in Residence at GV).

Technology News Tech News machine learning technology science investing startups medicine life sciences
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

S4E8: Dave Munichiello on Investing in AI’s Future

September 20, 2023 14:30 - 27 minutes - 25.2 MB

Throughout the fourth season of Theory and Practice, we explored emerging human-like artificial intelligence and robots. We asked if we could learn as much about ourselves as we do about the machines we use. The series has covered safety guardrails for AI, empathic AI communication, communication between minds and machines, robotic surgery, computers that smell, and using AI to understand human vision. The most recent episode with Google DeepMind's Dr. Clément Farabet illuminates ho...

S4E7: Google DeepMind’s Clément Farabet on AI Reasoning

September 13, 2023 14:30 - 44 minutes - 40.8 MB

In this season of Theory and Practice, we explore newly emerging human-like artificial intelligence and robots — and how we can learn as much about ourselves, as humans, as we do about the machines we use. As we near the end of Season 4, we explore whether decision-making and judgment are still the final preserve of humans. Our guest for Episode 7 is Dr. Clément Farabet, VP of Research at Google DeepMind. For the past 15 years, Dr. Farabet’s work has been guided by a central missio...

S4E6: MIT’s James DiCarlo on Reverse-Engineering Human Sight with AI

September 06, 2023 14:30 - 45 minutes - 41.2 MB

Season 4 of our Theory and Practice podcast investigates the powerful new world of AI applications and what it means to be human in the age of human-like artificial intelligence. Episode 6 explores what happens when AI is explicitly used to understand humans. In this episode, we're joined by James DiCarlo, the Peter de Florez Professor of Neuroscience at Massachusetts Institute of Technology and Director of the MIT Quest for Intelligence. Trained in biomedical engineering and medic...

S4E5: Mapping the World of Smell to Broaden Diagnostics in Healthcare

August 31, 2023 18:00 - 44 minutes - 41 MB

On Season 4 of Theory and Practice, Anthony Philippakis and Alex Wiltschko explore newly emerging human-like artificial intelligence and robots — and how we can learn as much about ourselves, as humans, as we do about the machines we use. The series has delved into many aspects of AI, from safety guardrails to empathic communication to robotic surgery and how computers can make decisions. In episode 5, we explore how machine learning helped create a map of odor and how that technol...

S4E4: Moravec’s Paradox and the Evolution of Surgical Robotics

August 23, 2023 14:30 - 44 minutes - 41 MB

In Season 4 of the Theory and Practice podcast, we’ve been investigating the powerful new world of AI applications. We’ve explored how to build safety guardrails into AI-driven healthcare, what the future holds for empathetic AI communication, and how humans can control computers with imperceptible movements of their hands. For episode 4, we turn to surgical robots with the help of Dr. Catherine Mohr, President of the Intuitive Foundation, who played an integral role in developing ...

S4E3: Computational Neuroscientist Dr. Thomas Reardon on Communication between Minds and Machines

August 16, 2023 14:30 - 46 minutes - 42.2 MB

On Season 4 of Theory and Practice, Anthony Philippakis and Alex Wiltschko explore newly emerging human-like artificial intelligence and robots — and how we can learn as much about ourselves, as humans, as we do about the machines we use. The series will delve into many aspects of AI: from communication to robotic surgery and decision-making. In episode 3, we explore how humans will control computers in the future with Dr. Thomas Reardon. Dr. Reardon founded CTRL-Labs and is an ear...

S4E2: Google DeepMind’s Dr. Claire Cui on The Next Frontier for Large Language Models

August 09, 2023 14:45 - 46 minutes - 42.7 MB

On Season 4 of the Theory and Practice podcast, GV’s Anthony Philippakis and Osmo’s Alex Wiltschko explore being human in the age of AI. Guests this season dive into areas including AI communication, robotic surgery, and decision-making. Episode 2 explores how machine learning evolved to where it is today. Anthony and Alex’s guest is Dr. Claire Cui, a computer scientist from Google DeepMind. They discuss the underlying architecture of LLMs, how self-supervising algorithms work, and...

S4E1: Being Human in the Age of AI: How to Responsibly Introduce AI into Healthcare

August 02, 2023 14:45 - 41 minutes - 38.2 MB

On Season 4 of the Theory and Practice podcast, hosts Anthony Philippakis and Alex Wiltschko explore the many aspects of what it means to be human in the new era of artificial intelligence: from communication to robotic surgery and decision-making. In episode 1, Dr. Greg Corrado, Distinguished Scientist and Head of Health AI at Google Health, explains how to responsibly introduce AI into healthcare. AI has proven itself in detecting diabetic eye disease, managing the risk of cardio...

S3E7: Calico’s Cynthia Kenyon on The Science of Aging

April 19, 2022 15:19 - 49 minutes - 45.1 MB

For millennia, humans have believed that aging is inevitable. Yet thirty years ago, the work of Professor Cynthia Kenyon and her colleagues showed that a single gene mutation in a worm doubled its lifespan and postponed the diseases of aging. Recent work on the naked mole rat, a mammal like us, has shown that risk of death need not increase with age. In the final episode of this season of Theory and Practice, we explore the genetic, cellular, and molecular basis of aging with Profe...

Calico’s Cynthia Kenyon on The Science of Aging

April 19, 2022 15:19 - 49 minutes - 45.1 MB

For millennia, humans have believed that aging is inevitable. Yet thirty years ago, the work of Professor Cynthia Kenyon and her colleagues showed that a single gene mutation in a worm doubled its lifespan and postponed the diseases of aging. Recent work on the naked mole rat, a mammal like us, has shown that risk of death need not increase with age. In the final episode of this season of Theory and Practice, we explore the genetic, cellular, and molecular basis of aging with Profe...

S3E6: Geoffrey Hinton on the Exploration of Thought

April 12, 2022 15:32 - 49 minutes - 45.5 MB

What is a thought? Some may think that question is quite abstract, but it has huge implications for science and computer design. If we cannot define a human thought, how can we know if a computer can think? Only then can true Artificial Intelligence be achieved. This week we speak to the “godfather of deep learning”, Professor Geoffrey Hinton, a cognitive psychologist and computer scientist. He is now an emeritus Professor at the University of Toronto, and an engineering fellow at...

Geoffrey Hinton on the Exploration of Thought

April 12, 2022 15:32 - 49 minutes - 45.5 MB

What is a thought? Some may think that question is quite abstract, but it has huge implications for science and computer design. If we cannot define a human thought, how can we know if a computer can think? Only then can true Artificial Intelligence be achieved. This week we speak to the “godfather of deep learning”, Professor Geoffrey Hinton, a cognitive psychologist and computer scientist. He is now an emeritus Professor at the University of Toronto, and an engineering fellow at...

The Future of Psychiatry with Professor Karl Deisseroth

April 05, 2022 15:20 - 43 minutes - 39.6 MB

Psychiatry is changing and will be unrecognizable in the next 10-20 years, given our new understanding about the role of brain circuits in the generation of emotions and behavior. This week we talk to Professor Karl Deisseroth, D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University and the Howard Hughes Medical Institute. We discuss his work on optogenetics and the insights it has given into the workings of the human brain. Professor...

S3E5: The Future of Psychiatry with Professor Karl Deisseroth

April 05, 2022 15:20 - 43 minutes - 39.6 MB

Psychiatry is changing and will be unrecognizable in the next 10-20 years, given our new understanding about the role of brain circuits in the generation of emotions and behavior. This week we talk to Professor Karl Deisseroth, D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University and the Howard Hughes Medical Institute. We discuss his work on optogenetics and the insights it has given into the workings of the human brain. Professor...

An Exploration of Protein Folding with Professor David Baker

March 29, 2022 15:25 - 43 minutes - 40.3 MB

Using machine learning to predict how a protein folds helps solve a riddle in biology. But it is just the start. These algorithms open up new opportunities to explore the physiological processes that have eluded research, adapt and create proteins for therapeutic purposes, and even power nano-molecular machines. This week we speak with Professor David Baker about the enormous scope for making new proteins and how that translates into practical uses to tackle diseases, such as Covi...

S3E4: An Exploration of Protein Folding with Professor David Baker

March 29, 2022 15:25 - 43 minutes - 40.3 MB

Using machine learning to predict how a protein folds helps solve a riddle in biology. But it is just the start. These algorithms open up new opportunities to explore the physiological processes that have eluded research, adapt and create proteins for therapeutic purposes, and even power nano-molecular machines. This week we speak with Professor David Baker about the enormous scope for making new proteins and how that translates into practical uses to tackle diseases, such as Covi...

The Future of Cancer Medicine with Dr. Jay Bradner, President of Novartis Institutes for BioMedical Research

March 22, 2022 15:45 - 46 minutes - 42.3 MB

In the last 20 years or so, many new cancer treatments have emerged that provide greater precision and targeting of cancer cells. Today, we have a better understanding of the genetic components of cancer. Through novel technology and cutting-edge science, we’re now able to understand how the accumulation of molecular alterations in the genome leads to the coding of proteins that can promote uncontrolled cell division. New treatments are emerging at the genetic and molecular level...

S3E3: The Future of Cancer Medicine with Dr. Jay Bradner, President of Novartis Institutes for BioMedical Research

March 22, 2022 15:45 - 46 minutes - 42.3 MB

In the last 20 years or so, many new cancer treatments have emerged that provide greater precision and targeting of cancer cells. Today, we have a better understanding of the genetic components of cancer. Through novel technology and cutting-edge science, we’re now able to understand how the accumulation of molecular alterations in the genome leads to the coding of proteins that can promote uncontrolled cell division. New treatments are emerging at the genetic and molecular level...

S3E2: Breaking Barriers in Gene Editing with Harvard Professor David Liu

March 15, 2022 15:40 - 42 minutes - 38.7 MB

Gene editing is the process by which alterations are made to DNA. There are three major challenges: make precise edits at a chosen site, make edits that do not result in subsequent mutations, and have an editing process flexible enough to address the mutations which cause human disease. This week we talk to Professor David Liu of Harvard University’s Department of Chemistry and Chemical Biology. They discuss the progress that has been made to overcome these challenges, following...

Breaking Barriers in Gene Editing with Harvard Professor David Liu

March 15, 2022 15:40 - 42 minutes - 38.7 MB

Gene editing is the process by which alterations are made to DNA. There are three major challenges: make precise edits at a chosen site, make edits that do not result in subsequent mutations, and have an editing process flexible enough to address the mutations which cause human disease. This week we talk to Professor David Liu of Harvard University’s Department of Chemistry and Chemical Biology. They discuss the progress that has been made to overcome these challenges, following...

The "Dark Genome" with Dr. Rosana Kapeller-Lieberman

March 08, 2022 16:49 - 47 minutes - 43.3 MB

For the third season of Theory and Practice, we wanted to ask: what lies ahead for the intersection of life sciences and data sciences in the next ten years? In this episode, we explore the vastness of the "dark genome" and why "junk DNA" has been overlooked for so many decades. Our guest is Dr. Rosana Kapeller-Lieberman, A GV Fellow and the CEO of Rome Therapeutics with over 25 years’ experience in science and therapeutics. Rosana discusses her team's scientific approach, and how...

S3E1: The "Dark Genome" with Dr. Rosana Kapeller-Lieberman

March 08, 2022 16:49 - 47 minutes - 43.3 MB

For the third season of Theory and Practice, we wanted to ask: what lies ahead for the intersection of life sciences and data sciences in the next ten years? In this episode, we explore the vastness of the "dark genome" and why "junk DNA" has been overlooked for so many decades. Our guest is Dr. Rosana Kapeller-Lieberman, A GV Fellow and the CEO of Rome Therapeutics with over 25 years’ experience in science and therapeutics. Rosana discusses her team's scientific approach, and how...

S2E10: Bonus: The Patient's Perspective with Julia Vitarello

June 10, 2021 15:50 - 1 hour - 68.4 MB

We first shared Julia's daughter's story a few weeks ago in our interview with Dr Timothy Yu about the first "N of 1" drug trial. Tim recounted the journey in developing her treatment, and the intellectual and operational challenges that he faced in order to find a therapy and get it approved. Today we hear Julia's perspective, as a parent who desperately looked for ways to help her child, Mila. All too often in these cases, there are no readily available therapies, and most pat...

Bonus: The Patient's Perspective with Julia Vitarello

June 10, 2021 15:50 - 1 hour - 68.4 MB

We first shared Julia's daughter's story a few weeks ago in our interview with Dr Timothy Yu about the first "N of 1" drug trial. Tim recounted the journey in developing her treatment, and the intellectual and operational challenges that he faced in order to find a therapy and get it approved. Today we hear Julia's perspective, as a parent who desperately looked for ways to help her child, Mila. All too often in these cases, there are no readily available therapies, and most pat...

Julia Vitarello

June 10, 2021 15:50 - 1 hour - 68.4 MB

Julia Vitarello is the mother of Mila Makovec, and the Founder and CEO of Mila’s Miracle Foundation. Episode links: Theory and Practice - Tim Yu Mila's Miracle Foundation This Is Today photo journal Mila's story (YouTube)

Aviv Regev, Genentech

June 03, 2021 14:27 - 46 minutes - 42.7 MB

Aviv Regev is a computational biologist and Executive Vice President of Genentech Research and Early Development. She was professor at the Broad Institute of MIT and Harvard and at the Department of Biology of the Massachusetts Institute of Technology, as well as investigator at the Howard Hughes Medical Institute.

S2E9: Genentech’s Aviv Regev on the Promise of Single Cell Genomics

June 03, 2021 14:27 - 46 minutes - 42.7 MB

It's rare to meet a true visionary, someone who sees where the world can go before anyone else sees it. And it's even rarer to meet someone who not only recognizes the opportunity, but also has the conviction and energy to make it a reality. For us, the person who most exemplifies these characteristics is Dr. Aviv Regev, who leads Genentech's Research and Early Development (gRED) team. Human genetics has had a transformative impact on drug development. Single cell genomics is at a ...

Genentech’s Aviv Regev on the Promise of Single Cell Genomics

June 03, 2021 14:27 - 46 minutes - 42.7 MB

It's rare to meet a true visionary, someone who sees where the world can go before anyone else sees it. And it's even rarer to meet someone who not only recognizes the opportunity, but also has the conviction and energy to make it a reality. For us, the person who most exemplifies these characteristics is Dr. Aviv Regev, who leads Genentech's Research and Early Development (gRED) team. Human genetics has had a transformative impact on drug development. Single cell genomics is at a ...

Dr. Amy Abernethy

May 27, 2021 16:04 - 53 minutes - 48.5 MB

Dr. Amy Abernethy is an oncologist, specialist in palliative care medicine, researcher, previous Professor of Medicine at Duke University School of Medicine, previous Scientific and Medical Chief Officer of Flatiron Health, and previous Principal Deputy Commissioner of the FDA.

S2E8: Dr. Amy Abernethy on Closing the Gap Between Clinical Practice and Clinical Research

May 27, 2021 16:04 - 53 minutes - 48.5 MB

Physicians make very big decisions in people's lives. Whether or not to put in a heart valve, whether to do a stent or surgery, what chemotherapy to dose. We often make these big decisions with very little data for decision support. This has to change. As we discuss in this episode, the future of medicine will involve advanced machine learning to improve clinical decision making, and better ways to match patients to personalized therapies. Dr. Amy Abernethy is an oncologist, specia...

Dr. Amy Abernethy on Closing the Gap Between Clinical Practice and Clinical Research

May 27, 2021 16:04 - 53 minutes - 48.5 MB

Physicians make very big decisions in people's lives. Whether or not to put in a heart valve, whether to do a stent or surgery, what chemotherapy to dose. We often make these big decisions with very little data for decision support. This has to change. As we discuss in this episode, the future of medicine will involve advanced machine learning to improve clinical decision making, and better ways to match patients to personalized therapies. Dr. Amy Abernethy is an oncologist, specia...

Dr. David Altshuler on Translating the Human Genome Project Into Benefits for Human Health

May 20, 2021 16:00 - 43 minutes - 39.8 MB

David Altshuler is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. I first met David when I was a medical student, and I spent my last year of my MD-PhD working in his lab at Massachusetts General Hospital. At the time, a new type of DNA sequencer (Solexa, soon to be acquired by Illumina) had just arrived at the Broad, and I raised my hand to be one of the people in his lab to get it up and running. At the time, most of David's lab...

David Altshuler, Vertex Pharmaceuticals

May 20, 2021 16:00 - 43 minutes - 39.8 MB

David Altshuler: Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals.

S2E7: Dr. David Altshuler on Translating the Human Genome Project Into Benefits for Human Health

May 20, 2021 16:00 - 43 minutes - 39.8 MB

David Altshuler is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. I first met David when I was a medical student, and I spent my last year of my MD-PhD working in his lab at Massachusetts General Hospital. At the time, a new type of DNA sequencer (Solexa, soon to be acquired by Illumina) had just arrived at the Broad, and I raised my hand to be one of the people in his lab to get it up and running. At the time, most of David's lab...

S2E6: Dr. Tim Yu on Running the First “N of 1” Drug Trial

May 13, 2021 17:14 - 51 minutes - 47.2 MB

Every so often, someone comes up with a new idea that is truly visionary. The first time you see it, you may not immediately appreciate how transformational it might become. As an attending physician in Boston Children's Hospital's Division of Genetics and Genomics, Tim was caring for a young patient with a devastating genetic mutation. He suspected her condition could be treated with an adaptation of an existing class of therapies, and he also knew that she was likely the only per...

Timothy Yu, Boston Children's Hospital

May 13, 2021 17:14 - 51 minutes - 47.2 MB

Dr. Timothy Yu is Attending Physician, Division of Genetics and Genomics, and head of the Yu lab at Boston Children's Hospital. He is also Associate Professor of Pediatrics at Harvard Medical School. He walks us through his experience running the first "N of 1" drug trial for a young patient with a devastating genetic mutation.

Dr. Tim Yu on Running the First “N of 1” Drug Trial

May 13, 2021 17:14 - 51 minutes - 47.2 MB

Every so often, someone comes up with a new idea that is truly visionary. The first time you see it, you may not immediately appreciate how transformational it might become. As an attending physician in Boston Children's Hospital's Division of Genetics and Genomics, Tim was caring for a young patient with a devastating genetic mutation. He suspected her condition could be treated with an adaptation of an existing class of therapies, and he also knew that she was likely the only per...

S2E5: Dr. Krishna Yeshwant on Exploring the Intersection of Technology and Life Sciences

May 06, 2021 15:53 - 45 minutes - 41.9 MB

Krishna Yeshwant is Managing Partner at GV, and a practicing physician at Brigham and Women’s Hospital in Boston. Krishna embodies this mix of being both an intellectual and a business person. Most of his investments are at the intersection of life sciences and data sciences, like Flatiron Health, Foundation Medicine, EQRx, and Imagen. He's interested in finding companies at that interface. You'll hear him talk about starting his first company, making the mistake of hiring his fri...

Dr. Krishna Yeshwant on Exploring the Intersection of Technology and Life Sciences

May 06, 2021 15:53 - 45 minutes - 41.9 MB

Krishna Yeshwant is Managing Partner at GV, and a practicing physician at Brigham and Women’s Hospital in Boston. Krishna embodies this mix of being both an intellectual and a business person. Most of his investments are at the intersection of life sciences and data sciences, like Flatiron Health, Foundation Medicine, EQRx, and Imagen. He's interested in finding companies at that interface. You'll hear him talk about starting his first company, making the mistake of hiring his fri...

Krishna Yeshwant, GV

May 06, 2021 15:53 - 45 minutes - 41.9 MB

Dr. Krishna Yeshwant is Managing Partner at GV, and a practicing physician at Brigham and Women’s Hospital in Boston.

Caroline Uhler, MIT

April 29, 2021 16:25 - 44 minutes - 41.1 MB

Theory and Practice speaks with Dr. Caroline Uhler, currently the Henry L. and Grace Doherty associate professor in EECS (Electrical Engineering & Computer Science) and IDSS (Institute for Data, Systems and Society) at MIT, and associate member of the Broad Institute where she is co-director of the Eric and Wendy Schmidt Center.

Dr. Caroline Uhler on Harnessing the Power of Machine Learning to Drive New Discoveries in Biology

April 29, 2021 16:25 - 44 minutes - 41.1 MB

Theory and Practice speaks with Dr. Caroline Uhler, currently the Henry L. and Grace Doherty associate professor in EECS (Electrical Engineering & Computer Science) and IDSS (Institute for Data, Systems and Society) at MIT, and associate member of the Broad Institute where she is co-director of the Eric and Wendy Schmidt Center. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scient...

S2E4: Dr. Caroline Uhler on Harnessing the Power of Machine Learning to Drive New Discoveries in Biology

April 29, 2021 16:25 - 44 minutes - 41.1 MB

Theory and Practice speaks with Dr. Caroline Uhler, currently the Henry L. and Grace Doherty associate professor in EECS (Electrical Engineering & Computer Science) and IDSS (Institute for Data, Systems and Society) at MIT, and associate member of the Broad Institute where she is co-director of the Eric and Wendy Schmidt Center. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scient...

Dr. Jennifer Listgarten on Solving Biological Questions with Creative Machine Learning

April 22, 2021 16:08 - 47 minutes - 43.9 MB

This week on Theory and Practice, we speak with Jennifer Listgarten, a professor in UC Berkeley's Electrical Engineering and Computer Sciences department and the Center for Computational Biology. Before Jennifer joined UC Berkeley she spent ten years at Microsoft, working in the New England Research Lab. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theo...

S2E3: Dr. Jennifer Listgarten on Solving Biological Questions with Creative Machine Learning

April 22, 2021 16:08 - 47 minutes - 43.9 MB

This week on Theory and Practice, we speak with Jennifer Listgarten, a professor in UC Berkeley's Electrical Engineering and Computer Sciences department and the Center for Computational Biology. Before Jennifer joined UC Berkeley she spent ten years at Microsoft, working in the New England Research Lab. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theo...

Jennifer Listgarten, UC Berkeley

April 22, 2021 16:08 - 47 minutes - 43.9 MB

Theory and Practice speaks with Professor Jennifer Listgarten, Professor in UC Berkeley's Electrical Engineering and Computer Sciences Department (EECS) and the Center for Computational Biology, and Chan Zuckerberg investigator. Relevant links: - Jennifer Listgarten - 2018 Berkeley Faculty Profile  - 2020: Seminar on Machine Learning - 2021 Interview for Berkeley Scientific Journal

S2E2: Sir Rory Collins on the Power of Math and Biomedical Data to Solve Today’s Health Problems

April 15, 2021 16:17 - 38 minutes - 35.4 MB

We speak with Professor Sir Rory Collins, Head of Nuffield Department of Population Health at Oxford University and BHF (British Heart Foundation) Professor of Medicine and Epidemiology. Professor Collins is also Principal Investigator and Chief Executive of the UK Biobank. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theory and Practice opens the doors...

Sir Rory Collins on the Power of Math and Biomedical Data to Solve Today’s Health Problems

April 15, 2021 16:17 - 38 minutes - 35.4 MB

We speak with Professor Sir Rory Collins, Head of Nuffield Department of Population Health at Oxford University and BHF (British Heart Foundation) Professor of Medicine and Epidemiology. Professor Collins is also Principal Investigator and Chief Executive of the UK Biobank. Theory and Practice is a presentation of GV and Google AI. Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theory and Practice opens the doors...

Sir Rory Collins, UK Biobank

April 15, 2021 16:17 - 38 minutes - 35.4 MB

Theory and Practice speaks with Professor Sir Rory Collins, Head of Nuffield Department of Population Health at Oxford University and BHF (British Heart Foundation) Professor of Medicine and Epidemiology. Professor Collins is also Principal Investigator and Chief Executive of the UK Biobank. Relevant links: - Sir Rory Collins - Oxford University - British Heart Foundation - UK Biobank

S2E1: A Conversation with the Broad Institute's Anne Carpenter

April 08, 2021 16:18 - 41 minutes - 37.6 MB

On this season of Theory and Practice we explore one of the art of being a great biologist – marrying a problem to a solution, choosing the right biological question, and pairing it with the right technology. Dr. Anne Carpenter is the inventor of CellProfiler and designed a method for coloring and analyzing cells. She works at the Broad Institute as the Senior Director of the Imaging Platform and is an Institute Scientist. One of the things that strikes me about Anne's work is how...